Pharmacokinetics, Safety, Tolerability, and Immunogenicity of Two Formulations of SB5 in Healthy Male Subjects
Status:
Completed
Trial end date:
2021-05-15
Target enrollment:
Participant gender:
Summary
This study is to evaluate to compare the pharmacokinetics, safety, tolerability, and
immunogenicity of two formulations of SB5 in healthy male subjects.